Synageva Biopharma (GEVA) Widens Q4 Loss to $1/Share
Tweet Send to a Friend
Synageva Biopharma (NASDAQ: GEVA) reported Q4 EPS of ($1.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
